Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Respir Physiol Neurobiol ; 284: 103569, 2021 02.
Artículo en Inglés | MEDLINE | ID: mdl-33144273

RESUMEN

Current study investigates the immunomodulatory effects of T. stocksianum using mouse model of ovalbumin (OVA)-induced allergic asthma. The mice were treated with methanolic extract, n-hexane, and ethyl acetate fractions for consecutive 7 days along with intranasal challenge. The mRNA expression levels of interleukin-4 (IL-4), IL-5, Aquaporin-1 (AQP1) and Aquaporin-5 (AQP5) were evaluated using reverse transcription polymerase chain reaction. The data showed that T. stocksianum significantly reduced airway inflammation as indicated by reduced inflammatory cell infiltration in lungs, and attenuated total and differential leukocyte counts both in blood and BALF. Expression levels of pro-inflammatory IL-4 and IL-5 in lungs were also found significantly reduced. T. stocksianum significantly reduced pulmonary edema as indicated by reduced lung wet/dry ratio and goblet cell hyperplasia. AQP1 and AQP5 expression levels were also found elevated in treatment groups. In conclusion, T. stocksianum possesses anti-asthmatic activity which may be attributed to reduction in IL-4 and IL-5 expression levels, and elevation in AQP1 and AQP5 expression levels.


Asunto(s)
Acuaporina 1/efectos de los fármacos , Acuaporina 5/efectos de los fármacos , Asma/tratamiento farmacológico , Hipersensibilidad/tratamiento farmacológico , Factores Inmunológicos/farmacología , Inflamación/tratamiento farmacológico , Interleucina-4 , Interleucina-5 , Edema Pulmonar/tratamiento farmacológico , Enfermedades Respiratorias/tratamiento farmacológico , Teucrium , Animales , Asma/inmunología , Modelos Animales de Enfermedad , Femenino , Hipersensibilidad/inmunología , Factores Inmunológicos/administración & dosificación , Inflamación/inmunología , Masculino , Ratones , Ratones Endogámicos BALB C , Extractos Vegetales/administración & dosificación , Edema Pulmonar/inmunología , Enfermedades Respiratorias/inmunología
2.
Respir Physiol Neurobiol ; 266: 39-46, 2019 08.
Artículo en Inglés | MEDLINE | ID: mdl-31015030

RESUMEN

Ziziphora clinopodioides has been frequently used as an anti asthmatic plant in traditional medication. Recent work explores the anti-asthmatic activity of Z. clinopodioides in allergen-induced asthmatic mice. Intraperitoneal sensitization followed by intranasal challenge were given with ovalbumin (allergen) to develop allergic asthma. Investigational groups of animals were administered with drug methylprednisolone (MP) (15 mg/kg body weight), n-hexane fraction, ethylacetate fraction, and methanolic extract of Z. clinopodioides extract (500 mg/kg b.w.) for successive 07 days. Hematoxyline and eosin (H&E) and periodic acid-Schiff (PAS) stains were used to evaluate histopathological parameters on lung tissues. As an index of lungs tissues edema, wet/dry weight ratio of lungs was determined. Evaluation of expression levels of AQP1, AQP5, IL4, and IL5 was conducted by using RT-PCR. The data exhibited that both Z. clinopodioides and MP attenuated differential and total leukocyte counts in hematological examination i.e. in BALF and blood. Treatment with Z. clinopodioides also caused suppression of inflammatory cell infiltration and expression levels of IL4 and IL5, the later could have caused attenuation of pulmonary inflammation. The study also found decline in lung wet/dry ratio and goblet cellh hyperplasia in treated groups which indicates amelioration of lung edema. Treatment with Z. clinopodioides significantly increased the expression levels of aquaporin-1 and -5, which could have led to reduction in lung edema. The treatment with MP showed comparable results to Z. clinopodioides. Current investigation revealed that Z. clinopodioides possessed anti-asthmatic property which might be accredited to upregulagted AQP1 and AQP5 levels and downregulated IL4 and IL5 levels.


Asunto(s)
Antiasmáticos/farmacología , Acuaporinas/efectos de los fármacos , Asma/tratamiento farmacológico , Citocinas/efectos de los fármacos , Inflamación/tratamiento farmacológico , Mentha , Extractos Vegetales/farmacología , Edema Pulmonar/tratamiento farmacológico , Animales , Antiasmáticos/administración & dosificación , Antiinflamatorios/farmacología , Asma/etiología , Modelos Animales de Enfermedad , Regulación hacia Abajo , Femenino , Hipersensibilidad/complicaciones , Metilprednisolona/farmacología , Ratones , Ovalbúmina/inmunología , Extractos Vegetales/administración & dosificación , Edema Pulmonar/etiología , Regulación hacia Arriba
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA